Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTpximpact Hldg Regulatory News (TPX)

Share Price Information for Tpximpact Hldg (TPX)

Share Price is delayed by 15 minutes
Get Live Data
57.50    0.00 (0.00%)
Bid:
56.00
Ask:
59.00
Spread: 3.00 (5.357%)
Market Cap: £54.49m
TPX Live PriceLast checked at - London Stock Exchange

Intraday Tpximpact Hldg Share Chart

Appointment of Group Advisor

1 Jul 2021 07:00

RNS Number : 7542D
Panoply Holdings PLC (The)
01 July 2021
Β 

1 July 2021

The Panoply Holdings PLC

("The Panoply", or the "Group")

Β 

Appointment of Group Advisor

The Panoply Holdings PLC, the technology-enabled services group focused on digital transformation,Β is pleased to announce the appointment of Noel Gordon as a Senior Advisor to the Group, with a focus on the healthcare sector.

Noel brings a wealth of experience in public healthcare and the not-for-profit sector; he was Chair of NHS Digital from 2016-2020, has served as Chair of Healthcare UK's advisory board from 2017-2021 and served as a non-executive director of NHS England from 2014-2021. His current roles include Board positions at Assura PLC, Bestway Panacea Holdings and the HCA UK.

Working with The Panoply's senior leadership team, Noel will leverage his significant experience to advise on strategic opportunities, new market developments and potential partnerships as well as working with the Group's portfolio companies on their growth plans in the health and care sector.

Neal Gandhi, Chief Executive Officer of The Panoply, said:

"Alongside the acquisition of Nudge Digital announced today, the appointment of Noel Gordon as an advisor to the Group bolsters our already considerable healthcare proposition.

As we continue to grow our pipeline of opportunities, we will undoubtedly benefit from his deep market knowledge and experience in this field."

Noel Gordon, Senior Adviser to The Panoply, said:

"I am delighted to join Neal and his team in their important mission to bring new digital technologies and capabilities to the journey of transformation in our health and care sector.

Innovation in the delivery of healthcare is more important than ever to patients, clinicians and managers; the array of capabilities being assembled in The Panoply provides a powerful toolkit to enable the health system to change the way we live and work."

Enquiries:

Β 

The Panoply Holdings

Neal Gandhi (CEO)

Oliver Rigby (CFO)

Β 

Stifel Nicolaus Europe Limited

(Nomad and Joint Broker)

Β 

Via Alma PR

Β 

Β 

+44 (0)207 710 7600

Fred Walsh

Alex Price

Β 

Β 

Dowgate Capital Limited

(Joint Broker)

James Serjeant

David Poutney

Nicholas Chambers

Β 

Β 

+44 (0)203 903 7715

Alma PR

(Financial PR)

Susie Hudson

Kieran Breheny

Matthew Young

panoply@almapr.co.uk

+44 (0)203 405 0209

Β 

Β 

Β 

About The Panoply

The Panoply is a technology-enabled services group, built to service clients' digital transformation needs. Founded in 2016, with the aim of identifying and acquiring best-of-breed specialist information technology, design and innovation consulting businesses, the Group collaborates with its clients to deliver the technology outcomes they're looking for at the pace that they expect and demand.

The Group is being increasingly recognised as a leading alternative digital transformation provider to the UK public services sector, with c.70% of its client base representing the public sector and c.30% representing the commercial sector.

More information is available at www.thepanoply.com.

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
APPEAFKEDSXFEAA
Date   Source Headline
11th Jun 20267:00 amRNSShare Incentive Plan
1st Jun 20267:00 amRNSTPXimpact announces £16m contract with the MoJ
11th May 20267:00 amRNSShare Incentive Plan
22nd Apr 20267:00 amRNSFull Year Trading Update and Notice of Results
17th Apr 20264:17 pmRNSNotification of Major Holdings
17th Apr 20267:00 amRNSShare Incentive Plan
20th Mar 20267:00 amRNSShare Incentive Plan
24th Feb 20267:00 amRNSQ3 Trading Update: EBITDA guidance Upgrade
17th Feb 20267:00 amRNSContract Uplift
12th Feb 20267:01 amRNSTPXimpact announces £39m Contract with DEFRA
12th Feb 20267:00 amRNSShare Incentive Plan
11th Feb 20267:00 amRNSTPXimpact announces £22m NHS England contract
9th Jan 20267:00 amRNSShare Incentive Plan
9th Dec 20257:00 amRNSShare Incentive Plan
8th Dec 20255:19 pmRNSHolding(s) in Company
2nd Dec 20252:45 pmRNSExercise of Options, PDMR, & Total Voting Rights
2nd Dec 20257:00 amRNSUnaudited Interim Results
24th Nov 20257:30 amRNSAppointment of Nominated Adviser and Broker
14th Nov 20257:00 amRNSShare Incentive Plan
5th Nov 20257:00 amRNSFirst Half Update & Notice of Results
14th Oct 20255:29 pmRNSShare Incentive Plan
25th Sep 20254:37 pmRNSResult of AGM
9th Sep 20257:00 amRNSShare Incentive Plan
8th Sep 20255:25 pmRNSExercise of Options & PDMR Dealings
8th Sep 20253:27 pmRNSNotification of Major Holdings
5th Sep 202512:37 pmRNSIssuance of Shares & Total Voting Rights
22nd Aug 20257:00 amRNSNotice of AGM
21st Aug 20257:00 amRNSChange of Auditor
12th Aug 20256:05 pmRNSReplacement: FY25 & FY26 Share Awards
11th Aug 20257:00 amRNSPosting of Annual Report
4th Aug 20259:24 amRNSReplacement: FY25 & FY26 Share Awards
4th Aug 20257:00 amRNSFY25 & FY26 Long-Term Incentive Share Award
30th Jul 20257:00 amRNSDebt Facility Renewal Update
14th Jul 20257:00 amRNSAppointment of non-executive director
10th Jul 20257:00 amRNSShare Incentive Plan
24th Jun 20257:00 amRNSUnaudited preliminary results
16th Jun 20259:00 amRNSNotice of Results
12th Jun 20251:17 pmRNSShare Incentive Plan
14th May 20257:00 amRNSTrading Update and Contract Wins
22nd Apr 20257:00 amRNSResignation of Non-Executive Director
11th Apr 20257:00 amRNSShare Incentive Plan
12th Mar 20257:00 amRNSShare Incentive Plan
28th Feb 20253:26 pmRNSChange of Registered Office Address
12th Feb 20257:00 amRNSShare Incentive Plan
6th Feb 20257:00 amRNSQ3 Trading Update and Revised Outlook
3rd Feb 20257:00 amRNSConfirmation of CFO Appointment
15th Jan 20257:00 amRNSShare Incentive Plan
18th Dec 20247:00 amRNSDirectorate Change - Group CFO retirement
11th Dec 20247:00 amRNSShare Incentive Plan
5th Dec 20247:00 amRNSExercise of Options and PDMR Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.